Jason Nehmad, MD
Hospitalist · Neptune, NJNPI 1780920645
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Amgen at 56.8% of the total. Reporting peaked in 2020 at $4,529 and has fallen 93.2% since, to $309 in 2025. Among hospitalist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $78.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- Johnson & Johnson$1K
- Integra Lifesciences Corporation$782
- AbbVie$591
- Abbott$127
- Esperion Therapeutics, Inc.$124
- plus $395 from 8 others
What the payments were for
- Consulting fees$4,05057%
- Food & beverage$3,08443%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 2 | $4,050 |
| Johnson & Johnson(2 entities) | 37 | $1,063 |
| Integra Lifesciences Corporation | 5 | $782 |
| AbbVie(2 entities) | 31 | $591 |
| Abbott | 1 | $127 |
| Esperion Therapeutics, Inc. | 1 | $124 |
| AstraZeneca | 3 | $102 |
| Pfizer | 2 | $88 |
| Davol Inc. | 1 | $86 |
| Boehringer Ingelheim | 3 | $41 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $27 |
| Portola Pharmaceuticals, LLC | 2 | $27 |
| Merck | 1 | $13 |
| Melinta Therapeutics, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$4,050
- INTEGRA$1,918
- INTEGRA DERMAL REGENERATION TEMPLATE$639
- PRIMATRIX$639
- XARELTO$357
- CYTAL$286
- XCM Biologic Tissue Matrix$150
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$127
- NEXLIZET$124
- NEXLETOL$124
How this compares
$7,134 in reported general payments places this provider in the 95th percentile of 567 hospitalist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 32 | $456 |
| Atorvastatin Calcium | 31 | $433 |
| Metoprolol Succinate | 19 | $162 |
| Rosuvastatin Calcium | 12 | $150 |
| Amlodipine Besylate | 18 | $133 |
| Carvedilol | 13 | $113 |
| Levothyroxine Sodium | 13 | $100 |
| Escitalopram Oxalate | 11 | $90 |
| Methylprednisolone | 11 | $74 |
| Furosemide | 18 | $58 |
| Metoprolol Tartrate | 13 | $55 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Neptune
- Sameh GirgisNeptune$6K
- Mohammed UsmanToms River$33K
- Justin BaptistAtlantic City$23K
- Jhonsua Jimenez AriasMorristown$15K
- Ahmed HassaninMorristown$15K
- Mohamed BakrAtlantic City$8K
- Rebecca ZweiflerMorristown$6K
- Scott KaufmanMount Holly$6K
- Kunal ParmarPompton Plains$6K
- Arjun PatelCamden$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.